title: Proceedings of the 4th International Workshop of the Adrenoleukodystrophy International Research Group (ALD-IRG), University of York, 3 September 1998.
authors.affiliation: Department of Clinical Chemistry, Birmingham Children's Hospital, UK.
authors.forename: S
authors.initials: S
authors.lastname: Alger
authors.forename: A
authors.initials: A
authors.lastname: Green
authors.forename: W
authors.initials: W
authors.lastname: Köhler
authors.forename: P
authors.initials: P
authors.lastname: Sokolowski
authors.forename: H
authors.initials: H
authors.lastname: Moser
mesh_terms: D000326:Adrenoleukodystrophy / Q000178:diet therapy / Q000188:drug therapy* / Q000235:genetics; D000328:Adult; D002648:Child; D002985:Clinical Protocols; D004338:Drug Combinations; D004739:England; D004883:Erucic Acids / Q000009:adverse effects / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D011446:Prospective Studies; D012189:Retrospective Studies; D014304:Triolein / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D004883:Erucic Acids; D000960:Hypolipidemic Agents; C079420:Lorenzo's oil; D014304:Triolein; D008148:Lovastatin